Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis (TICE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by Institut Claudius Regaud
Sponsor:
Information provided by (Responsible Party):
Institut Claudius Regaud
ClinicalTrials.gov Identifier:
NCT00864318
First received: March 16, 2009
Last updated: March 26, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2029
  Estimated Primary Completion Date: September 2021 (Final data collection date for primary outcome measure)